Madhushree Zope
Overview
Explore the profile of Madhushree Zope including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
49
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zope M, Sinai C, Phiri W, Tembo B, Mpata S, Yuggu B, et al.
J Pediatr Surg
. 2025 Feb;
:162167.
PMID: 39939237
Background: Kamuzu Central Hospital (KCH), a tertiary care facility, serves as 1 of 2 pediatric surgical centers in Malawi, a resource limited country in southeastern Africa. We sought to understand...
2.
Hinson C, Alkhatib J, Williams L, Zope M, Ameh E, Nthumba P
Am J Surg
. 2025 Feb;
:116230.
PMID: 39893055
No abstract available.
3.
Kasmirski J, Zope M, Gutnik L, Warde M
World J Surg
. 2024 Dec;
49(2):313-315.
PMID: 39694863
No abstract available.
4.
Mott N, Zope M, Reynolds I, Tade Y, Serra G, Long J, et al.
Am J Surg
. 2024 Oct;
241:116009.
PMID: 39419639
No abstract available.
5.
Sumra H, Riner A, Arjani S, Tasnim S, Zope M, Reyna C, et al.
Am J Surg
. 2022 Jun;
224(4):1179-1181.
PMID: 35643633
No abstract available.
6.
Arjani S, Tasnim S, Sumra H, Zope M, Riner A, Reyna C, et al.
Am J Surg
. 2021 Sep;
223(2):432-435.
PMID: 34482952
No abstract available.
7.
Alatrash G, Qiao N, Zhang M, Zope M, Perakis A, Sukhumalchandra P, et al.
Clin Cancer Res
. 2019 Jan;
25(8):2610-2620.
PMID: 30647079
Purpose: Inefficient homing of adoptively transferred cytotoxic T lymphocytes (CTLs) to tumors is a major limitation to the efficacy of adoptive cellular therapy (ACT) for cancer. However, through fucosylation, a...
8.
Alatrash G, Kidwell K, Thall P, Di Stasi A, Chen J, Zope M, et al.
Bone Marrow Transplant
. 2018 Dec;
54(8):1245-1253.
PMID: 30532055
Conditioning regimens contribute significantly to outcomes following allogeneic stem cell transplantation (allo-SCT). Reduced-intensity conditioning (RIC) regimens provide lower toxicity at the cost of reduced efficacy compared with myeloablative conditioning (MAC)...
9.
Alatrash G, Perakis A, Kerros C, Peters H, Sukhumalchandra P, Zhang M, et al.
Clin Cancer Res
. 2018 Apr;
24(14):3386-3396.
PMID: 29661776
PR1 is a human leukocyte antigen (HLA)-A2 nonameric peptide derived from neutrophil elastase (NE) and proteinase 3 (P3). We have previously shown that PR1 is cross-presented by solid tumors, leukemia,...
10.
Cathepsin G Is Expressed by Acute Lymphoblastic Leukemia and Is a Potential Immunotherapeutic Target
Khan M, Carmona S, Sukhumalchandra P, Roszik J, Philips A, Perakis A, et al.
Front Immunol
. 2018 Feb;
8:1975.
PMID: 29422892
Cathepsin G (CG) is a myeloid azurophil granule protease that is highly expressed by acute myeloid leukemia (AML) blasts and leukemia stem cells. We previously identified CG1 (FLLPTGAEA), a human...